Sartorius Stedim Biotech (OTCMKTS:SDMHF) Stock Price Up 4.4% – Here’s Why

Sartorius Stedim Biotech S.A. (OTCMKTS:SDMHF) shares shot up 4.4% during mid-day trading on Monday . The stock traded as high as $240.01 and last traded at $233.4860. Approximately 17,671 shares traded hands during trading, an increase of 723% from the average session volume of 2,147 shares. The stock had previously closed at $223.75.

Wall Street Analysts Forecast Growth

Separately, UBS Group raised Sartorius Stedim Biotech to a “buy” rating in a report on Thursday, August 20th. Two analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy”.

Sartorius Stedim Biotech Stock Up 3.8%

The business’s 50 day moving average price is $212.62 and its 200-day moving average price is $203.09.

Sartorius Stedim Biotech Company Profile

Sartorius Stedim Biotech SA (OTCMKTS: SDMHF) is a global provider of bioprocessing equipment and services for the biopharmaceutical industry. The company develops and manufactures technologies that support the development and production of vaccines, monoclonal antibodies, therapeutic proteins and cell? and gene?based therapies. Its solutions address both upstream processes—such as cell cultivation and fermentation—and downstream processes, including filtration, centrifugation and chromatography.

Key product offerings include single?use bioreactors and mixers, modular filtration assemblies, prepacked chromatography columns, and a wide range of cell culture media and buffer systems.